blogkasce.blogg.se

Rapt therapeutics
Rapt therapeutics









  1. #Rapt therapeutics registration
  2. #Rapt therapeutics zip

Proposed maximum aggregate offering price. Includes the aggregate offering price of additional shares that the underwriters have the option to purchase toĬalculated pursuant to Rule 457(o) under the Securities Act of 1933, as amended, based on an estimate of the

#Rapt therapeutics registration

☐Ĭommon Stock, $0.0001 par value per shareĮstimated solely for the purpose of calculating the registration fee pursuant to Rule 457(o) under the Transition period for complying with any new or revised financial accounting standards provided pursuant to Section 7(a)(2)(B) of the Securities Act. If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended

rapt therapeutics

“emerging growth company” in Rule 12b-2 of the Exchange Act. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company” and Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. This Form is a post-effective amendment filed pursuant to Rule 462(d) under the Securities Act, check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same Securities Act registration statement number of the earlier effective registration statement for the same offering. If this Form is a post-effective amendment filed pursuant to Rule 462(c) under the Securities Act, check the following box and list the Securities for an offering pursuant to Rule 462(b) under the Securities Act, check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering. If this Form is filed to register additional Under the Securities Act of 1933, as amended, check the following box. If any of the securities being registered on this form are to be offered on a delayed or continuous basis pursuant to Rule 415

#Rapt therapeutics zip

(Name, address, including zip code, and telephone number, including area code, of agent for service)Īpproximate date of commencement of proposed sale to the public: As soon as practicable after this Registration Statement is declared

rapt therapeutics

(Address, including zip code, and telephone number, including area code, of registrant’s principal executive offices) (Exact name of registrant as specified in its charter) As filed with the Securities and Exchange Commission on July 5, 2019











Rapt therapeutics